ATE283841T1 - Verfahren zur herstellung von amlodipin- benzolsulfonat - Google Patents

Verfahren zur herstellung von amlodipin- benzolsulfonat

Info

Publication number
ATE283841T1
ATE283841T1 AT99933061T AT99933061T ATE283841T1 AT E283841 T1 ATE283841 T1 AT E283841T1 AT 99933061 T AT99933061 T AT 99933061T AT 99933061 T AT99933061 T AT 99933061T AT E283841 T1 ATE283841 T1 AT E283841T1
Authority
AT
Austria
Prior art keywords
methyl
amlodipine benzenesulfonate
producing amlodipine
producing
formula
Prior art date
Application number
AT99933061T
Other languages
English (en)
Inventor
Janos Fischer
Katalin Szoeke
Laszlo Dobay
Sandor Levai
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE283841T1 publication Critical patent/ATE283841T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
AT99933061T 1999-07-05 1999-07-05 Verfahren zur herstellung von amlodipin- benzolsulfonat ATE283841T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (1)

Publication Number Publication Date
ATE283841T1 true ATE283841T1 (de) 2004-12-15

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933061T ATE283841T1 (de) 1999-07-05 1999-07-05 Verfahren zur herstellung von amlodipin- benzolsulfonat

Country Status (24)

Country Link
US (1) US6596874B1 (de)
EP (1) EP1196383B1 (de)
JP (1) JP3764386B2 (de)
KR (1) KR100585442B1 (de)
CN (1) CN1141297C (de)
AT (1) ATE283841T1 (de)
AU (1) AU777565B2 (de)
BG (1) BG65657B1 (de)
CA (1) CA2376540C (de)
CZ (1) CZ300509B6 (de)
DE (1) DE69922417T2 (de)
DK (1) DK1196383T3 (de)
EA (1) EA004208B1 (de)
EE (1) EE05398B1 (de)
ES (1) ES2234272T3 (de)
HK (1) HK1044151B (de)
MX (1) MXPA01013407A (de)
NO (1) NO321714B1 (de)
NZ (1) NZ517013A (de)
PL (1) PL194193B1 (de)
PT (1) PT1196383E (de)
SK (1) SK285611B6 (de)
UA (1) UA72768C2 (de)
WO (1) WO2001002360A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
ATE454890T1 (de) 2001-07-06 2010-01-15 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (de) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetonsolvat von Phthaloylamlodipin
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
WO2001002360A1 (en) 2001-01-11
NO20020029L (no) 2002-03-05
UA72768C2 (en) 2005-04-15
EE05398B1 (et) 2011-04-15
MXPA01013407A (es) 2003-09-04
DE69922417T2 (de) 2005-12-01
NO321714B1 (no) 2006-06-26
EP1196383A1 (de) 2002-04-17
SK22002A3 (en) 2002-05-09
BG65657B1 (bg) 2009-05-29
BG106164A (en) 2002-07-31
HK1044151B (zh) 2004-09-10
DE69922417D1 (de) 2005-01-05
AU777565B2 (en) 2004-10-21
SK285611B6 (sk) 2007-04-05
NO20020029D0 (no) 2002-01-04
EE200100686A (et) 2003-04-15
CN1352634A (zh) 2002-06-05
CA2376540A1 (en) 2001-01-11
CZ20014690A3 (cs) 2002-04-17
PL352493A1 (en) 2003-08-25
ES2234272T3 (es) 2005-06-16
EA200200125A1 (ru) 2002-06-27
HK1044151A1 (en) 2002-10-11
JP3764386B2 (ja) 2006-04-05
NZ517013A (en) 2003-08-29
DK1196383T3 (da) 2005-02-21
PT1196383E (pt) 2005-03-31
US6596874B1 (en) 2003-07-22
CA2376540C (en) 2007-03-13
KR100585442B1 (ko) 2006-06-02
PL194193B1 (pl) 2007-05-31
KR20020022760A (ko) 2002-03-27
AU4923799A (en) 2001-01-22
EA004208B1 (ru) 2004-02-26
EP1196383B1 (de) 2004-12-01
CZ300509B6 (cs) 2009-06-03
JP2003503477A (ja) 2003-01-28
CN1141297C (zh) 2004-03-10

Similar Documents

Publication Publication Date Title
ATE283841T1 (de) Verfahren zur herstellung von amlodipin- benzolsulfonat
ATE292116T1 (de) Verfahren zur herstellung von donepezilderivaten
IS6435A (is) Aðferð til framleiðslu á sítalóprami
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE389631T1 (de) Verfahren zur herstellung von fexofenadinen
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60000402T2 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
ATE290528T1 (de) Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure
IS6050A (is) Ný aðferð við að framleiða alendrónsýru
ATE479661T1 (de) Verfahren zur herstellung von pestiziden verbindungen
ATE359990T1 (de) Verfahren zur herstellung von 3,5- bisalkylphenolen
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE259785T1 (de) Verfahren zur herstellung von 2-alkylthio- substituierten benzoesäurederivaten
ATE250569T1 (de) Verfahren zur herstellung von 1- aminomethylcyclohexanessigsäure
ATE240937T1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
ATE236135T1 (de) Verfahren zur herstellung von 4,6- dichlorpyrimidin
DK1163257T3 (da) Fremgangsmåde til fremstilling af 4,4-dimethyl-3beta-hydroxypregna-8,14-dien-21-carboxylsyreestere og mellemprodukter i fremgangsmåden
ATE273289T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
HUP0002772A2 (hu) Eljárás királis 3,4-dehidroprolinok előállítására
ATE260264T1 (de) Verfahren zur herstellung von oxazol-derivaten
DE60128336D1 (de) Eine zwischenverbindung und verfahren zu deren herstellung
UA33033A (uk) Спосіб одержання безилату амлодипіну
ATE259774T1 (de) Verfahren zur herstellung von 6,6-dialkoxy-5- hydroxy-3-oxo-hexansäureestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1196383

Country of ref document: EP